Tutorials
BOM:531633 (India)  
Lincoln Pharmaceuticals Ltd logo

Lincoln Pharmaceuticals Ltd

₹ 309.50 (-1.59%) Aug 8
P/E:
9.07
P/B:
1.46
Market Cap:
₹ 6.30B ($ 79.09M)
Enterprise V:
₹ 5.16B ($ 64.73M)
Volume:
2.13K
Avg Vol (2M):
8.03K
Volume:
2.13K
Market Cap ₹:
6.30B
Market Cap $:
79.09M
PE Ratio:
9.07
Avg Vol (2-Month):
8.03K
Enterprise Value ₹:
5.16B
Enterprise Value $:
64.73M
PB Ratio:
1.46
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Lincoln Pharmaceuticals Ltd
Science City Road, Lincoln House, Behind Satyam Complex, Sola, Ahmedabad, GJ, IND, 380060
Description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.
Name Current Vs Industry Vs History
Cash-To-Debt 56.97
Equity-to-Asset 0.81
Debt-to-Equity 0.01
Debt-to-EBITDA 0.02
Interest Coverage 60.23
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.8
Distress
Grey
Safe
Beneish M-Score -2.44
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 69.79
9-Day RSI 63
14-Day RSI 59.87
6-1 Month Momentum % -11.83
12-1 Month Momentum % -14.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.9
Quick Ratio 3.1
Cash Ratio 1.29
Days Inventory 93.6
Days Sales Outstanding 91.94
Days Payable 108.77

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 0.48
Dividend Payout Ratio 0.04
Forward Dividend Yield % 0.48
5-Year Yield-on-Cost % 0.48

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₹) 4,721.233
EPS (TTM) (₹) 34.66
Beta 0.82
Volatility % 40.52
14-Day RSI 59.87
14-Day ATR (₹) 9.7119
20-Day SMA (₹) 307.6125
12-1 Month Momentum % -14.95
52-Week Range (₹) 255 - 414.75
Shares Outstanding (Mil) 20.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lincoln Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data